Men vs Women on Semaglutide: Who Loses More Weight?

It's a common question in weight loss: do men lose weight faster than women? When it comes to GLP-1 medications like semaglutide, the answer is nuanced. While the headline numbers may suggest a slight male advantage in certain metrics, the full picture reveals important differences in how men and women respond — differences that go far beyond the scale.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Individual results vary. Consult your healthcare provider about your personal weight loss goals.

What the Clinical Trials Show

The STEP clinical trial program provides the most comprehensive data on semaglutide for weight management. While these trials were not specifically designed to compare outcomes between sexes, subgroup analyses offer valuable insights.

Overall Weight Loss

In the STEP 1 trial, the average weight loss with semaglutide 2.4 mg was approximately 14.9% of body weight over 68 weeks. Subgroup analyses showed:

Men: Slightly higher average percentage of body weight lost (approximately 16–18% in some analyses)
Women: Average weight loss closer to the overall mean (approximately 14–15%)

However, these differences should be interpreted carefully. Men in the trials had higher average starting weights, which means they lost more weight in absolute pounds while potentially losing a similar or slightly higher percentage.

Rate of Weight Loss

Men tended to lose weight faster in the initial months of treatment, with the gender gap narrowing over time. By 68 weeks, the difference in percentage weight loss was relatively small. This pattern mirrors what's seen with conventional weight loss methods — men often see faster initial results, but the long-term picture is more balanced.

Why Men May Lose Weight Faster Initially

Several physiological factors contribute to the tendency for men to lose weight more quickly at the start of treatment:

Higher Baseline Metabolic Rate

Men typically have more lean muscle mass than women, resulting in a higher basal metabolic rate (BMR). This means men burn more calories at rest, and the caloric deficit created by semaglutide's appetite suppression translates to faster weight loss in absolute terms.

More Visceral Fat

Men tend to carry more visceral (abdominal) fat than premenopausal women. Visceral fat is more metabolically active and responsive to weight loss interventions than subcutaneous fat. Semaglutide's preferential effect on visceral fat means men with more of this fat type may see faster initial results. Learn more about how semaglutide targets fat on our how it works page.

Hormonal Differences

Testosterone supports muscle maintenance and fat metabolism. While testosterone levels are often low in obese men, even reduced levels contribute to a more favorable metabolic environment for weight loss compared to estrogen-dominant metabolism in premenopausal women.

Less Hormonal Variability

Women's weight can fluctuate significantly throughout the menstrual cycle due to water retention and hormonal changes. Men don't have this monthly variability, which can make their weight loss appear more consistent and linear on a day-to-day basis.

Where Women May Have Advantages

The story isn't one-sided. Women may have certain advantages in their GLP-1 weight loss journey:

Greater Appetite Response

Some research suggests that women may experience a more pronounced appetite-suppressing effect from GLP-1 medications. This could be related to differences in GLP-1 receptor distribution or hormonal interactions with the appetite-regulating system.

Better Adherence

Studies consistently show that women are more likely to adhere to prescribed treatment regimens, attend follow-up appointments, and engage with lifestyle modification programs. These behavioral factors significantly influence long-term outcomes.

More Comprehensive Health Engagement

Women are more likely to seek healthcare proactively and engage with comprehensive weight management programs that include nutrition counseling, behavioral support, and regular monitoring — all of which improve outcomes.

Side Effect Differences

The side effect profile of semaglutide shows some gender-based patterns:

Side Effect	Men	Women
Nausea	Somewhat less frequent	More commonly reported
Constipation	Similar rates	Similar rates
Diarrhea	Similar rates	Similar rates
Hair loss	Less commonly reported	More commonly reported
Gallstones	Lower baseline risk	Higher baseline risk
Reduced alcohol desire	Commonly reported	Commonly reported

Body Composition Changes

One of the most important differences between men and women on semaglutide isn't total weight lost — it's what that weight consists of.

Men

Greater absolute fat loss, particularly visceral fat
Higher risk of muscle loss in absolute terms (starting from higher baseline muscle mass)
More dramatic waist circumference reduction
Testosterone improvement with weight loss can support muscle preservation

Women

Proportionally similar fat loss but from different areas (hips, thighs, arms)
Lower absolute muscle loss (starting from lower baseline)
More noticeable changes in subcutaneous fat distribution
Potential hormonal changes affecting menstrual cycles
Greater concern about loose skin due to differences in skin elasticity

Health Outcome Differences

The health benefits of semaglutide-assisted weight loss manifest differently in men and women:

Cardiovascular Health

Men start with higher baseline cardiovascular risk and often see more dramatic improvements in blood pressure and lipid profiles. The SELECT trial showed cardiovascular event reduction in both sexes, though men's higher baseline risk means a greater absolute benefit.

Metabolic Health

Both sexes show significant improvements in fasting glucose, HbA1c, and insulin sensitivity. Men may see slightly greater improvements in glucose metabolism due to greater visceral fat loss.

Reproductive Health

This is where the differences are most pronounced. Men often see testosterone improvement, better erectile function, and improved fertility. Women may experience menstrual cycle changes, increased fertility, and must consider contraception and pregnancy planning.

Practical Implications

Understanding these differences helps set realistic expectations and optimize treatment:

For couples using semaglutide together: Don't compare results directly. Different starting points, hormonal environments, and body compositions mean different trajectories.
For men: Your advantage in speed should not lead to complacency. Prioritize resistance training and protein intake to preserve the muscle mass that gives you that metabolic edge.
For women: Slower initial results do not mean less effective treatment. Focus on overall health improvements — metabolic markers, energy, mobility — rather than comparing your rate of loss to men.
For both: Long-term outcomes are more similar than short-term results. By one year, the gender gap in weight loss percentage narrows significantly.

Visit our treatments page to explore personalized GLP-1 treatment options.

Frequently Asked Questions

My husband and I are both on semaglutide and he's losing weight faster. Is that normal?

Yes, this is common and expected, particularly in the first few months. Men typically have higher metabolic rates and more metabolically responsive visceral fat. The gap usually narrows over time, and health improvements are significant for both sexes.

Do men need a higher dose of semaglutide?

No. The dosing protocol for semaglutide is the same for men and women — a graduated titration up to 2.4 mg weekly for weight management. Dosing is based on tolerability and response, not gender.

Are men less likely to have side effects?

Some data suggests men may report nausea less frequently, but overall side effect profiles are similar. Individual variation is greater than gender-based variation for most side effects.

Does semaglutide work differently for premenopausal vs. postmenopausal women?

Postmenopausal women may lose weight somewhat more slowly due to lower estrogen levels and reduced metabolic rate. However, semaglutide is effective in both groups. Postmenopausal women may benefit from combining semaglutide with HRT. Read more about GLP-1 for women over 50.

Is the weight regain risk different for men and women?

Both men and women are at risk for weight regain after stopping semaglutide. The pattern and rate of regain may differ based on hormonal and metabolic factors, but the importance of maintenance strategies — continued lifestyle changes, potentially continued low-dose medication — applies equally to both sexes.

The Bottom Line

Men may lose weight slightly faster and in slightly higher percentages on semaglutide, but both sexes achieve clinically significant and health-transforming results. The differences are driven by physiology — higher metabolic rate, more visceral fat, and testosterone-influenced fat metabolism in men — rather than by the medication working better in one sex.

What matters most is not who loses more weight, but whether the treatment produces meaningful health improvements for each individual. For both men and women, semaglutide delivers. Explore Trimi's treatment options to start your personalized weight loss journey.